Cargando…
Delivery of therapeutic oligonucleotides in nanoscale
Therapeutic oligonucleotides (TOs) represent one of the most promising drug candidates in the targeted cancer treatment due to their high specificity and capability of modulating cellular pathways that are not readily druggable. However, efficiently delivering of TOs to cancer cellular targets is st...
Autores principales: | Wu, Lei, Zhou, Wenhui, Lin, Lihua, Chen, Anhong, Feng, Jing, Qu, Xiangmeng, Zhang, Hongbo, Yue, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379367/ https://www.ncbi.nlm.nih.gov/pubmed/34466734 http://dx.doi.org/10.1016/j.bioactmat.2021.05.038 |
Ejemplares similares
-
The delivery of therapeutic oligonucleotides
por: Juliano, Rudolph L.
Publicado: (2016) -
Nonviral delivery systems for antisense oligonucleotide therapeutics
por: Huang, Si, et al.
Publicado: (2022) -
Nanoscale Self-Assembly for Therapeutic Delivery
por: Yadav, Santosh, et al.
Publicado: (2020) -
Delivery of oligonucleotide‐based therapeutics: challenges and opportunities
por: Hammond, Suzan M, et al.
Publicado: (2021) -
Delivery of therapeutic oligonucleotides with cell penetrating peptides()
por: Boisguérin, Prisca, et al.
Publicado: (2015)